NCT03626831View on ClinicalTrials.gov

Effect of Evolocumab on Vascular Function

PHASE4CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

April 4, 2019

Primary Completion Date

April 15, 2021

Study Completion Date

July 12, 2021

Conditions
Atherosclerotic Cardiovascular Disease
Interventions
DRUG

Evolocumab Prefilled Syringe

Injection of study drug

DRUG

Placebos

Injection of placebo

Trial Locations (1)

91054

Clinical Research Center, Department of Nephrology and Hypertension, University of Erlangen-Nuremberg, Erlangen

All Listed Sponsors
lead

University of Erlangen-Nürnberg Medical School

OTHER

NCT03626831 - Effect of Evolocumab on Vascular Function | Biotech Hunter | Biotech Hunter